Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 66 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

NCT04090034

Conditions: Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations: Clinical Research Institute at Methodist Health System Dallas, Texas, United States

Methodist Dallas Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT05500391

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Aggressive Fibromatosis of Abdominal Wall (Disorder), +33 more
Locations: CHU Amiens Amiens, France

Centre François Baclesse Caen, France

Centre Oscar Lambret Lille, France

View Trial Details

Recruiting

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

NCT05746208

Conditions: High Grade Neuroendocrine Carcinoma, Any Site, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

NCT07404176

Conditions: Metastatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Tata Memorial Hospital, Mumbai, India Mumbai, Maharashtra, India

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Navi Mumbai, Maharashtra, India

View Trial Details

Recruiting

18F-DOPA II - PET Imaging Optimization

NCT04706910

Conditions: Basal Ganglia Diseases, Brain Diseases, Brain Neoplasms, +36 more
Locations: WC Mackenzie Health Science Centre / University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

NCT06055439

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +17 more
Locations: Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

Sapu003 in Advanced mTOR-sensitive Solid Tumors

NCT07369505

Conditions: Adenocarcinoma, Breast Cancer Metastatic, Carcinoma, +40 more
Locations: SOCRU Adelaide, Australia

View Trial Details

Recruiting

F-Tryptophan PET/CT in Human Cancers

NCT05556473

Conditions: Brain Diseases, Brain Neoplasms, Breast Cancer, +27 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

NCT06356467

Conditions: GEP-NET, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
Locations: IRCCS OSpedale San Raffaele Milan, Italy

View Trial Details